EWS
FLNA

Eagle Wealth Strategies’s Filana Therapeutics FLNA Stock Holding History

Eagle Wealth Strategies’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,000
Closed -$29.1K – 116
2025
Q3 		$29.1K Buy
+10,000
New +$23K 0.01% 105

Other funds holding FLNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Eagle Wealth Strategies's FLNA Position: Q4 2025 in Review

Eagle Wealth Strategies sold out of Filana Therapeutics (FLNA) in Q4 2025, closing a stake of 10,000 shares — an estimated $29.1K sold.

Eagle Wealth Strategies first reported a position in FLNA in Q3 2025 and held it in 1 quarter. The position peaked at $29.1K in Q3 2025. 107 funds tracked by Wall St. Rank hold FLNA as of Q4 2025.

  • Eagle Wealth Strategies reported no remaining Filana Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Eagle Wealth Strategies sold 10,000 Filana Therapeutics shares in Q4 2025, an estimated $29.1K.
  • Eagle Wealth Strategies first reported a position in Filana Therapeutics in Q3 2025 and held it in 1 quarter.
  • Eagle Wealth Strategies's Filana Therapeutics position peaked at $29.1K in Q3 2025.
  • 107 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2025.

Based on Eagle Wealth Strategies's 13F filing for Q4 2025, filed 6 Jan 2026.